Home « Education « Iron Toxicity News « Haematology News

**** Iron Overload News is a current news service provided by Doctor's Guide®. Novartis accepts no responsibility for and makes no representations or warranties regarding the content of the information presented. ****

Week of 7 March 2010
• Detection of paternal alleles in maternal plasma for non-invasive prenatal diagnosis of beta-thalassemia: A feasibility study in southern Chinese
• Characteristics of pericardial effusions in patients with leukemia
• Evaluation of the prognostic significance of Eosinophilia and Basophilia in a larger cohort of patients with myelodysplastic syndromes
• Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapy
• Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia
• Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndrome
Week of 28 February 2010
• Improved survival of children and adolescents with sickle cell disease
• Ocular manifestations of sickle cell disease
• Auditory-evoked response analysis in Brazilian patients with sickle cell disease
• Epigenetic therapy in Myelodysplastic Syndromes
• High-resolution oligonucleotide array comparative genomic hybridization study and methylation status of the RPS14 gene in de novo myelodysplastic syndromes
• Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies
• Epidemiological data on myelodysplastic syndrome patients under 50 years in a single center of Romania
• Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox
• Novel approaches for myelodysplastic syndromes: beyond hypomethylating agents
• Glomerular Hyperfiltration in Adult Sickle Cell Anemia: A Frequent Hemolysis Associated Feature
Week of 21 February 2010
• The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia
• The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population
• Mean corpuscular volume predicts prognosis in MDS patients with abnormal karyotypes
• Second unrelated donor hematopoietic cell transplantation for primary graft failure
Week of 14 February 2010
• Cause of death in patients with lower-risk myelodysplastic syndrome
• Prevalence of Growth hormone (GH) Deficiency in Adult polytransfused betaThalassaemia patients (TM) and correlation with Transfusional and Chelation Parameters
• A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance
• Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy
• Azacitidine for the treatment of lower risk myelodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program
Week of 7 February 2010
• Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C
• Increased adhesive properties of platelets in sickle cell disease: roles for alpha(IIb)beta(3)-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity
• The efficacy of tissue Doppler imaging in predicting myocardial iron load in patients with beta-thalassemia major: correlation with T2* cardiovascular magnetic resonance
• Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM
• Evaluation of the genetic basis of phenotypic heterogeneity in north Indian patients with Thalassemia major
• Host immunity affects survival in myelodysplastic syndromes: Independent prognostic value of the absolute lymphocyte count
• A case of posterior reversible encephalopathy syndrome in a child with myelodysplastic syndrome following allogenic bone marrow transplantation
Week of 31 January 2010
• Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia
• Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation
• Hydroxyurea for Children with Sickle Cell Disease
• A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study
• Prophylaxis for thromboembolism in internal medicine and family practice
• Update on Thalassemia: Clinical Care and Complications
Week of 24 January 2010
• Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major
• The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design
• Burden of Influenza-Related Hospitalizations Among Children With Sickle Cell Disease
• Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series
Week of 17 January 2010
• Cytogenetic evolution correlates with poor prognosis in myelodysplastic syndrome
• Myelodysplastic syndromes
• Azathioprine: Association with Therapy-related Myelodysplastic Syndrome and Acute Myeloid Leukemia
• Glomerular lesions in patients with sickle cell disease
• Myocardial Deformation in Patients with Beta-Thalassemia Major: A Speckle Tracking Echocardiographic Study
• Pregnancy in a woman with polycystic ovary syndrome and myelodysplastic syndrome (in the form of refractory anemia) treated with allogeneic hemopoietic stem-cell transplantation (alloHSCT)
• Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation
Week of 10 January 2010
• Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome
• Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features
• Paradoxically Increased Ferritin Level in a Beta-Thalassemia Major Patient following the Start of Deferasirox Chelation Therapy
• Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients
• Acute human parvovirus B19 infection and nephrotic syndrome in patients with sickle cell disease
• Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept
• Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia
• Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia
• HLA-mismatched hematopoietic SCT without in vitro T-cell depletion for myelodysplastic syndrome
• Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation
• A case of secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome, complicated with disseminated M. abscessus infection
• Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia
• Myelodysplastic syndromes
• High Prevalence of Sickle Cell Trait in African Americans with ESRD
Week of 3 January 2010
• Inpatient use of laxatives during opioid administration in children with sickle cell disease
• Ultrasonographic prediction of homozygous alpha(0)-thalassemia using placental thickness, fetal cardiothoracic ratio and middle cerebral artery Doppler: alone or in combination?
• Depression, suicidal ideation, and attempts in black patients with sickle cell disease
• Azacitidine in lower-risk myelodysplastic syndromes
• Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
• Preoperative use of alpha tocopherol does not increase the risk of hematoma in the face lift patient: a preliminary report
• Gonadal dysfunction and pelvic sonographic findings in females with thalassaemia major
• Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study
• Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease
• Munchausen syndrome by proxy mimicking as Gaucher disease
Week of 27 December 2009
• Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial
• DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
• Retinal mass in a case of pediatric myelodysplastic syndrome (refractory anemia with excess of blasts)
• Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
• Late-onset Hemorrhagic Cystitis in Children after Hematopoietic Stem Cell Transplantation for Thalassemia and Sickle Cell Anemia: A Prospective Evaluation of Polyoma (BK) Virus Infection and Treatment with Cidofovir
• Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia
• Overview on Practices in Thalassemia Intermedia Management Aiming for Lowering Complication-rates Across a Region of Endemicity: the OPTIMAL CARE study

The staff of medical writers at Doctor's Guide® may independently summarize and abstract the most current articles on subjects in oncology from the major peer-reviewed medical publications, such as JAMA, New England Journal of Medicine. In all cases, Doctor's Guide® cites the original sources of it's material.